Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.930
-0.120 (-3.93%)
At close: Mar 9, 2026, 4:00 PM EDT
2.970
+0.040 (1.37%)
After-hours: Mar 9, 2026, 5:50 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $112.69 million as of March 9, 2026. Its market cap has increased by 81.56% in one year.
Market Cap
112.69M
Enterprise Value
104.49M
1-Year Change
81.56%
Ranking
Category
Stock Price
$2.93
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $112.69M, a decrease of -9.59%. That is a compound annual growth rate of -2.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 117.31M | -5.28% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 127.37M |
| Alpha Cognition | 125.89M |
| Black Diamond Therapeutics | 122.50M |
| Genelux | 120.01M |
| Inovio Pharmaceuticals | 119.54M |
| Gossamer Bio | 115.89M |
| Oncolytics Biotech | 114.06M |
| Coya Therapeutics | 112.31M |